270
Participants
Start Date
March 26, 2024
Primary Completion Date
September 9, 2025
Study Completion Date
October 24, 2025
Cagrilintide
Participants will receive once-weekly cagrilintide subcutaneously.
Semaglutide
Participants will receive once-weekly semaglutide subcutaneously.
Placebo
Participants will receive placebo matched to cagrilintide and semaglutide subcutaneously.
Lenasia Clinical Trial Centre, Lenasia
Ashmed Medi-Centre, Cape Town
Oraderumaz (Pty) Ltd, Bloemfontein
Healthcare centre Zvezdara, Belgrade
Healthcare centre Nis, Niš
Policlinic for diabetes, Zaječar
Manassas Clinical Research Center, Manassas
TPMG Clinical Research, Newport News
University of North Carolina, Chapel Hill
Bioclinical Research Alliance, Miami
Healthcare centre Kragujevac, Kragujevac
Clinical Research Associates, Nashville
Elite Research Center, Flint
Iowa Diab & Endo Res Center, West Des Moines
Velocity Clinical Res-Dallas, Dallas
Synergy Groups Medical, Houston
PlanIt Research, PLLC, Houston
Solaris Clinical Research, Meridian
Palm Research Center Inc., Las Vegas
Valley Clinical Trials, Inc., Northridge
DIA - KONTROL s.r.o., Levice
The Second Affiliated Hospital of Nanjing Medical University-Endocrinology, Nanjing
The Second Affiliated Hospital of Nanjing Medical University_Nanjing, Nanjing
The Affiliated Hospital of Jiangsu University-Endocrinology, Zhenjiang
Jinan Central Hospital, Ji'nan
Jinan Central Hospital Affiliated to Shandong University, Jinan
Huaihe Hospital of Henan University-Endocrinology, Kaifeng
Huaihe Hospital of Henan University, Kaifeng
Manda Memorial Hospital_Internal Medicine, Sapporo-shi, Hokkaido
Tsuruma Kaneshiro Diabetes Clinic, Yamato-shi
Kumanomae Nishimura Internal Medical Clinic, Arakawa-ku, Tokyo
Akaicho Clinic, Chiba-shi, Chiba
Futata Tetsuhiro Clinic Meinohama_Internal medicine, Fukuoka-shi, Fukuoka
Kunisaki Makoto Clinic, Fukuoka-shi, Fukuoka
Sasaki Internal Medicine, Hokkaido
Naka Kinen Clinic_Internal medicine, Ibaraki
H.E.C Science Clinic, Kanagawa
Kyoto University Hospital, Kyoto-shi, Kyoto
Minami Akatsuka Clinic, Mito-shi, Ibaraki
Tokyo-Eki Center-building Clinic_Internal Medicine, Tokyo
Tokyo-Eki Center-building Clinic, Tokyo
Fukuwa Clinic_Internal Medicine, Tokyo
Kato Clinic of Internal Medicine_Internal Medicine, Tokyo
University Clinical Centre Nis, Niš
MOMED, s.r.o, Kráľovský Chlmec
SIN AZUCAR s.r.o., Malacky
ENRIN, s.r.o., Rimavská Sobota
LUDIA, s. r. o., Spišská Nová Ves
Prinshof Medical Campus, Pretoria
Clinical Trial Systems (CTC), Pretoria
Lead Sponsor
Novo Nordisk A/S
INDUSTRY